Immucell Corp
ICCC- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000811641
No open-market purchases or sales by Immucell Corp insiders were filed in the last 90 days; 31 institutions reported holding it in 13F filings for Q2 2026, worth $13.4M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Immucell Corp as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- 0 vs. Q1 2021
- Shares held
- 784.7K
- +37.8K (+5.1%) vs. Q1 2021
- Total value
- $7.45M
- +$255.0K (+3.5%) vs. Q1 2021
- New holders
- 1
- 5 more added
- Sold out
- 1
- 7 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ICCC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 31 | $13.4M |
| Q1 2026 | 27 | $8.67M |
| Q4 2025 | 26 | $7.87M |
| Q3 2025 | 27 | $8.08M |
| Q2 2025 | 25 | $9.00M |
| Q1 2025 | 27 | $5.79M |
| Q4 2024 | 27 | $6.21M |
| Q3 2024 | 22 | $4.27M |
| Q2 2024 | 28 | $5.56M |
| Q1 2024 | 25 | $5.39M |
| Q4 2023 | 28 | $5.31M |
| Q3 2023 | 30 | $5.47M |
| Q2 2023 | 31 | $5.32M |
| Q1 2023 | 30 | $5.42M |
| Q4 2022 | 26 | $5.41M |
| Q3 2022 | 26 | $7.26M |
| Q2 2022 | 29 | $8.53M |
| Q1 2022 | 27 | $9.18M |
| Q4 2021 | 29 | $7.04M |
| Q3 2021 | 28 | $8.05M |
| Q2 2021 | 28 | $7.45M |
| Q1 2021 | 28 | $7.20M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Immucell Corp; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 178,156 | $1.69M | 0.00% | −9,422−5.0% | Reduced |
| Vanguard Group Inc | 147,236 | $1.40M | 0.00% | +12,625+9.4% | Added |
| Overbrook Management Corp | 87,225 | $829.0K | 0.17% | −200−0.2% | Reduced |
| Bleichroeder LP | 60,607 | $576.0K | 0.09% | +60,607 | New |
| Morgan Stanley | 55,874 | $531.0K | 0.00% | +800+1.5% | Added |
| Perritt Capital Management Inc | 50,000 | $475.0K | 0.25% | −5,000−9.1% | Reduced |
| Strategic Financial Services, Inc, | 30,028 | $285.0K | 0.02% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 20,434 | $194.0K | 0.00% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 19,408 | $184.0K | 0.00% | +4,312+28.6% | Added |
| Shufro Rose & Co LLC | 17,909 | $170.0K | 0.01% | 00.0% | Unchanged |
| Flagship Harbor Advisors, LLC | 17,730 | $168.0K | 0.02% | +3,180+21.9% | Added |
| HighTower Advisors, LLC | 15,754 | $150.0K | 0.00% | 00.0% | Unchanged |
| Prosperity Planning, Inc. | 15,000 | $143.0K | 0.09% | 00.0% | Unchanged |
| Northern Trust Corp | 13,465 | $128.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 12,195 | $115.0K | 0.00% | −7,124−36.9% | Reduced |
| Minerva Advisors LLC | 11,958 | $113.0K | 0.06% | 00.0% | Unchanged |
| Mercer Global Advisors Inc | 11,202 | $106.0K | 0.00% | 00.0% | Unchanged |
| Envestnet Asset Management Inc | 11,202 | $106.0K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 2,032 | $20.0K | 0.00% | −22−1.1% | Reduced |
| UBS Group AG | 2,100 | $20.0K | 0.00% | 00.0% | Unchanged |
| HM Payson & Co | 2,000 | $19.0K | 0.00% | 00.0% | Unchanged |
| O'Shaughnessy Asset Management, LLC | 1,565 | $15.0K | 0.00% | −1,277−44.9% | Reduced |
| US Bancorp | 600 | $6.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 426 | $4.00K | 0.00% | −320−42.9% | Reduced |
| Harbour Investments, Inc. | 250 | $2.00K | 0.00% | 00.0% | Unchanged |
| Captrust Financial Advisors | 200 | $2.00K | 0.00% | 00.0% | Unchanged |
| Northwestern Mutual Wealth Management Co | 152 | $1.00K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 36 | $0 | 0.00% | +2+5.9% | Added |
| Wedge Capital Management L L P | 0 | $0 | 0.00% | −20,384−100.0% | Sold out |